206 related articles for article (PubMed ID: 9099982)
1. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
[TBL] [Abstract][Full Text] [Related]
2. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
3. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications.
Miettinen M; Kovatich AJ; Kärkkäinen P
Virchows Arch; 1997 Dec; 431(6):407-13. PubMed ID: 9428928
[TBL] [Abstract][Full Text] [Related]
4. Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid.
Fonseca E; Nesland JM; Sobrinho-Simões M
Histopathology; 1997 Oct; 31(4):330-5. PubMed ID: 9363448
[TBL] [Abstract][Full Text] [Related]
5. Molecular diversity of cytokeratins: significance for cell and tumor differentiation.
Moll R
Acta Histochem Suppl; 1991; 41():117-27. PubMed ID: 1725827
[TBL] [Abstract][Full Text] [Related]
6. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
7. Papillary and follicular neoplasms of the thyroid gland. Differential immunohistochemical staining with high-molecular-weight keratin and involucrin.
Liberman E; Weidner N
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):42-8. PubMed ID: 10937048
[TBL] [Abstract][Full Text] [Related]
8. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.
Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM
Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study.
Rochaix P; Monteil-Onteniente S; Rochette-Egly C; Caratero C; Voigt JJ; Jozan S
Histopathology; 1998 Oct; 33(4):337-43. PubMed ID: 9822923
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis.
Burstein DE; Nagi C; Wang BY; Unger P
Hum Pathol; 2004 Apr; 35(4):465-73. PubMed ID: 15116328
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.
Henzen-Logmans SC; Mullink H; Ramaekers FC; Tadema T; Meijer CJ
Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):347-54. PubMed ID: 2433835
[TBL] [Abstract][Full Text] [Related]
12. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin expression profiles in thyroid carcinomas.
Lam KY; Lui MC; Lo CY
Eur J Surg Oncol; 2001 Nov; 27(7):631-5. PubMed ID: 11669590
[TBL] [Abstract][Full Text] [Related]
14. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
Raphael SJ; McKeown-Eyssen G; Asa SL
Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
de Matos PS; Ferreira AP; de Oliveira Facuri F; Assumpção LV; Metze K; Ward LS
Histopathology; 2005 Oct; 47(4):391-401. PubMed ID: 16178894
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.
Baloch ZW; Abraham S; Roberts S; LiVolsi VA
Hum Pathol; 1999 Oct; 30(10):1166-71. PubMed ID: 10534163
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma.
Khurana KK; Truong LD; LiVolsi VA; Baloch ZW
Arch Pathol Lab Med; 2003 May; 127(5):579-83. PubMed ID: 12708901
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of cytokeratin and vimentin in benign and malignant thyroid lesions.
Uchida H; Nakayama I; Noguchi S
Acta Pathol Jpn; 1989 Mar; 39(3):169-75. PubMed ID: 2472733
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
Beesley MF; McLaren KM
Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
